ロード中...
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
PURPOSE: Metformin is the first-line antidiabetic drug and shown to reduce cardiovascular risk independent from its glucose lowering action. Particularly in poorly controlled diabetes, tissue factor (TF) is expressed in the vasculature and accounts for thromboembolic complications. Here, we aimed to...
保存先:
| 出版年: | Cardiovasc Drugs Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8266708/ https://ncbi.nlm.nih.gov/pubmed/32940892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-07040-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|